Papers by Author: Wei Zhong Yang

Paper TitlePage

Abstract: A co-precipitation preparation method and the properties of an ultraviolet (UV)-attenuating agent are described in this paper. The composite particles of ultra-fine zinc oxide and titanium oxide are used to attenuate UV radiation. Preparation of TiOSO4, ZnCl2 solution and the co-precipitation of the composite particles by alkali are included during the process. Various types of surfactants have been used to modify the composite particles. Particle sizes are determined by laser particle analyzer, and reflectance and absorption coefficient are determined by UV-VIS spectrophotometer. Results show that particle size of the composite particles as well as total reflectance and absorption coefficient depend on the surfactants, pH value, and carline temperature. The average sizes of zinc oxide and titanium oxide ultra-fine particles range from39 to 65 nm. Attenuation capability of ultraviolet radiation becomes stronger when the particle average sizes becomes smaller. Composites less than 40 nm with titanium oxide of rutile phase attenuate most effectively the ultraviolet radiation ranging from 280 nm to 390 nm.
822
Abstract: Bioactive composite of apatite-wollastonite(AW)/β-tricalcium phosphate (β-TCP) was prepared. The nucleation and growth of bio-apatite on the surface of AW/β-TCP ceramic in simulated body fluid (SBF) were investigated. The surface morphological structure, phase compositions and microstructure of the materials were characterized by scan electron microscopy (SEM), X-ray diffraction (XRD) and infrared spectroscopy (IR); Results show that the surfaces of the AW/β-TCP composite ceramic are covered with a layer of carbonate hydroxyapatite (HCA) when soaked in SBF, which indicates their bioactivity; Such HCA layer is composed of fine ball-like HA granules. With excellent bioactivity and bio-absorption, AW/β-TCP bioactive composite ceramic is expected to be a good candidate for bone substitutes and bone tissue engineering scaffolds.
1692
Abstract: Porous biodegradable scaffolds are widely used in bone tissue engineering to provide temporary templates for cellular attachment and matrix synthesis. Ideally, the degradation rate in vivo may be similar or slightly less than that of tissue formation, allowing for the maintenance of the scaffold structure and the mechanical support during early stages of tissue formation. Eventually, the 3-D spaces occupied by the porous scaffolds will be replaced by newly formed tissue. In this work, β-tricalcium phosphate/Poly-L lactide (β-TCP/PLLA) scaffolds with different proportions of β-TCP to PLLA were investigated. The effects of β-TCP proportions on degradation rate and mechanical strengths of the scaffolds were evaluated in simulated body fluid (SBF) at 37°C up to 42 days. Results show that: different proportions of β-TCP to PLLA have significant influence on degradation behaviors of the scaffolds, and mechanical strengths of the scaffolds with weight proportion of β-TCP to PLLA being 2 to 1 are much higher than those of the others during the degradation period. And in this period, the scaffolds biodegrade slowly, and Hydroxyl Carbonate Apatite (HCA) forms in the surface of the material.
1545
Abstract: Degradation of surface modified β-tricalcium phosphate (β-TCP) and poly L lactic acid (PLLA) composite scaffolds were investigated in vitro. Bending and compressive strengths were tested by electromechanical universal material testing machine. Molecular weight changes of lactic acid during degradation were measured by gel permeation chromatography (GPC). Phase composition of the surface after soaking was analyzed by Fourier transform infrared ray (FTIR). The surface and cross section of scaffold samples after degradation were observed by Scanning electron microscope (SEM).The results show that degradation speed can be controlled by adjusting the ratio of β-TCP to PLLA in the composite. PLLA can compound more closely with surface modified β-TCP than with non-modified one. The final compressive strength and bending strength of the scaffolds reach 7.11MPa and 2.20MPa respectively, which satisfies the need for bone tissue engineering scaffolds in clinic applications.
931
Abstract: The porous apatite-wollastonite bioactive glass-ceramic (AW-GG) was made from nano-precursor powders derived from sol-gel process, and shaped by dipping method with polymer foam. The physical-chemical properties, bioactivity and biocompatibility of the materials were studied by means of TG, XRD, SEM, TEM and so on. The bioactivity was investigated in simulated body fluid (SBF) and the biocompatibility was evaluated by co-culturing with marrow stromal cells (MSCs). The result shows that: the particle size of the AW precursor powders is 40~100nm; porous AW GC has three-dimensional pored structure with 300~500um macropores and 2~5um micropores; the materials possess high bioactivity and biocompatibility. Porous AW GC may therefore have great potential application as bone tissue engineering scaffold.
169
Abstract: Merwinite powders were synthesized by a sol-gel process. The bioactivity in vitro of merwinite was investigated by soaking the powders in simulated body fluid (SBF), the growth of hydroxyapatite(HAp) on the surface of the powder was evaluated in various time. It was found that hydroxyapatite was formed after soaking for 14 days. The results indicate that merwinite possessed apatite-formation ability might be a potential candidate biomaterial for hard tissue repair.
67
Showing 1 to 6 of 6 Paper Titles